Key Highlights
• Kimball Electronics paid roughly €90 million, equivalent to about $103 million, to acquire Helvoet medical CDMO.
• An escrow of approximately €1.8 million was established to secure seller obligations at closing.
• The transaction was financed through a mix of company cash reserves and existing credit facilities.
Kimball Electronics Inc. (NASDAQ: KE) announced the completion of its purchase of Helvoet Rubber & Plastics Technologies (India) Pvt. Ltd. A European medical contract development and manufacturing organization. The deal closed on July 1 2026, marking a strategic expansion of Kimball’s footprint in the medical device sector.
Deal Overview
The acquisition was executed for an all‑cash consideration of approximately €90 million, translating to roughly $103 million. This figure aligns with the company’s stated intent to broaden its product portfolio and geographic reach. The purchase price reflects the valuation of Helvoet’s specialized manufacturing capabilities.
Financial Terms
Kimball disclosed that the cash payment was supplemented by the use of its existing lines of credit, ensuring liquidity was preserved for ongoing operations. The combination of cash reserves and credit sources underscores the firm’s balanced approach to financing growth initiatives.
Escrow Arrangement
A portion of the purchase price, about €1.8 million, was placed in an escrow account at the time of closing. This escrow serves as security for the seller’s post‑closing obligations, safeguarding Kimball against potential adjustments or indemnity claims arising from the transaction.
Contractual Safeguards
The share purchase agreement incorporates standard representations, warranties, and indemnification clauses typical of cross‑border transactions. Termination rights and other customary provisions were also embedded to mitigate risks associated with the acquisition.
Investor Communication
Kimball scheduled a webcast for investors on the day of closing, July 1 2026, at 9 a.m. Eastern Time. The session was intended to provide additional details about the deal and to address shareholder questions. A formal press release accompanied the announcement, outlining the strategic rationale behind the acquisition.
Strategic Impact
By adding Helvoet’s medical CDMO services, Kimball Electronics enhances its ability to serve global medical device manufacturers. The move positions the company to capture a larger share of the growing demand for high‑precision polymer components in the healthcare industry.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...